DAY 1 – Friday 02nd October 2020

Nutrition Symposia

Sheela Krishnaswamy, Geetha Santhosh

9:30-9:50

Shilpa Joshi

How to step up to the challenge? Meeting protein
requirements in a vegetarian diet

9:50-10:10

Anjana Mohan

Rice and Diabetes - How PURE?

10:10-10:30

Usha Ayyagari

Low carb diet - An overview of the evidence

10:30-10:40

Discussion

Nandita Arun

10:40-11:00

Neeta Deshapande

Intermittent fasting for diabetes reversal

11:00-11:20

Chitra Selvan

Preserving healthy muscle during weight loss

11:20-11:40

Purvi Chawla

Does Instagram help in weight loss?

11:40-11:50

Discussion

Clinical Case Seminar

Neeta Deshpande

11:50 - 12:10

Panelists: Shalini Jaggi, Usha Ayyagari, Chitra Selvan

Weight loss and maintenance in women - challenges and solutions

Stories & Lessons

Anjali Bhat, Vinod Mittal

12:10-12:30
-->

S R Aravind

STENO 2 - A tale to tell in the journey of patient

12:30-12:50
-->

Bhavana Sosale

Managing Hypertension with Diabetes: ADVANCing Beyond Arbitrary BP Values

12:50-13:00

Discussion

13:00-14:00

Lunch break

Inflammation and Diabetes

A K Das

14:00-14:20
-->

Banshi Saboo

Role of Inflammation in Diabetes

14:20 - 14:40
-->

Bhavana Sosale

Hydroxychloroquine in Diabetes

14:40 - 14:50

Discussion

Basal Insulin Symposium

S Venkatraman

14:50-15:10

J J Mukherjee

Basal insulin initiation and titration in T2DM - An Indian Perspective

15:10-15:30

Shanshank R. Joshi

Comparing new basal insulins - Have we reached a verdict?

15:30-15:40

Discussion

Recent Advances

Muthukumaran Jaypaul

15:45-16:05

Rajiv Kovil

Mixtures or Coformulations - A Guidance

16:05-16:25

Manoj Chawla

GLP1RAS - extending CVOTs to Primary Prevention

16:25-16:35

Discussion

Diabetes and Depression - the INDEPENDENT way forward

V Mohan

16:40-16:55

Mohammed K. Ali

Introduction of Issue and Overview of INDEPENDENT Trial Findings

16:55-17:00

Nikhil Tandon

Context of why these Findings are Important in India

17:00-17:05

G R Sridhar

Role of Technology in Practice to Overcome Challenges

17:05-17:10

V Mohan

What are the Gaps in Research

17:10-17:25

Discussion

17:25-17:35

Opening Remarks

S V Madhu, Sanjay Agarwal

17:35-18:05

Chittaranjan S Yajnik

ADA-PRIMER AWARD LECTURE: Early Life Origins of Diabetes in India

18:05-18:30

Rohit N. Kulkarni

NAFLD - detecting biomarkers to counter an emerging epidemic

18:30-18:40

Discussion

B M Makkar, Abraham Oomman

18:40-19:05

Jane E. Reusch

Exercise in Cardiometabolic Risk Modification

19:05-19:30

Robert A. Gabbay

Overcoming Therapeutic Inertia

19:30-19:40

Discussion

19:40-19:55

Inauguration and ADA PRIMER Oration

K M Prasanna Kumar, Aravind S R

19:55-20:25

Robert H. Eckel

ADA PRIMER Oration

Neeta Deshpande, Usha Ayyagari

20:25-20:50

Allison Goldfine

Mechanisms of weight loss with surgery and
their implications for management of obesity and diabetes

20:50-21:15

Samuel Klein

Metabolic Effects of Medical Vs Surgical therapies for Weight loss

21:15-21:30

Discussion

21:30

Close for the day

Endocrine Updates

S Murthy

09:30-09:50

Arundati Das Gupta

Thyroid disease in the postpartum

09:50-10:10

Rucha Mehta

Thyroid disease in the elderly

10:10-10:30

Rajesh Rajput

Thyroid disease in the patient undergoing surgery

10:30-10:40

Discussion

Challenges in Endocrinology

K A V Subrahmanyam

10:40-11:00

A G Unnikrishnan

The Endocrinology of Longevity

11:00-11:20

Vageesh Ayyar

Approach to endocrine hypertension

11:20-11:40

Ganapathy Bantwal

COVID and the Endocrine System

11:40-11:50

Discussion

Krishna G. Seshadri

Clinical Case Seminar

11:50-12:10

Panelists: Bipin Sethi, Manoj Chadha, Rajesh Rajput Rucha Mehta

Clincal Case Seminar: Management of PCOS

Debate: Thionamides forever?

12:10-12:15

Arun Menon

Yes

12:15-12:30

Tejal Lathia

No

12:30-12:45

Rebuttal

12:45-12:50

Manoj Chadha

Balanced view

DAY 2 – Saturday 03rd October 2020

Insulin Workshop - overcoming challenges in Initiation to Intensification

K M Prasanna Kumar, Krishna G. Seshadri

11:00-11:10

K M Prasanna Kumar

Introduction to Insulin workshop

11:10-11:25

S R Aravind

Overcoming Inertia

11:25-11:40

Sanjay Agarwal

Invitation with Basal Insulin

11:40-11:55

Vijay Panikar

Analog vs Human Insulin - Know the Difference

11:55-12:10

Manoj Chawla

Insulin intensification beyond basal

12:10-12:30

Discussion

Dr Arpandev bhattacharyya

12:30-12:45

S R Aravind

Role of SGLT2i + DPP4i: Combination in early intensification

12:45-13:00

Kiron Varghese

Learning from EMPA REG to EMPEROR REDUCED

13:00-13:15

A H Zargar

Cardio Renal Continum of T2DM:
Simplifying the journey with the right DPP4i agent

13:15-13:30

Discussion

Challenging first line metformin therapy

L Sreenivasamurthy, Sai Kandula

13:45-14:05

K N Arun

Cardio-renal approach to management of diabetes with SLGT2is

14:05-14:25

Samit Ghosal

Early combination therapy to retard the progressive beta cell loss with DPP4is

14:25-14:35

Discussion

Hope for Resource Limited Settings

Anand Moses, Moideen M A

14:40 - 15:00

Jothydev Kesavadev

FDA approved biosimilar insulins

15:00-15:20

G Vijaykumar

Cost effective gliptins versus SUs

15:20-15:40

Bipin Sethi

Real world evidence with Remogliflozin

15:40-15:50

Discussion

Evolving evidence

Vasanth Kumar, Sadashiva Rao

15:55-16:15

Manisha Sahay

DAPA CKD - Fresh from the Oven

16:15-16:35

Arpan Dev Bhattacharyya

SGLT2i - from prevention to treatment

16:35-16:45

Discussion

India's tryst with twin epidemics- DM & CVD

M A Shekar, Rakesh Sahay

16:50-17:10

Krishna Seshadri

Diabetes and CVD a relook

17:10-17:30

Shashank Joshi

Evidence based approach to manage CV risk in Indian T2DM Patients

17:30-17:40

Discussion

Plenaries

Precision Medicine

K M Prasanna Kumar, S R Aravind

17:45 - 18:10

V Mohan

Indian Clusters and their place in precision medicine

18:10 - 18:35

Louis H. Phillipson

A Genomic Approach to Precision Medicine

18:35 - 19:00

John Buse

Personalising Diabetes Care

19:00 - 19:15

Discussion

Cardiometabolic symposium

Krishna G. Seshadri

19:20-19:30

Introduction

19:30-19:50

Tiny Nair

Cardiometabolic disease in India - Connecting the dots

19:50-20:10

Mike Blaha

Gaps in Cardiometabolic Care

20:10-20:30

Robert Eckel

Cardiometabolic Medicine - Proposal for a new subspecialty

20:30-21:00

Panel Discussion

Jayashree Gopal

21:00 - 21:25

Sunder Mudaliar

Fuel Metabolism as a Target for Diabetes - post SGLT2i scenario

21:25-21:30

Discussion

21:20

Close for the day

DAY 3 – Sunday 04th October 2020

Diabetes and COVID 19 I

Muruganathan A

10:00-10:20

Shashank R. Joshi

Psychological stress, COVID and Diabetes

10:20-10:40

Anoop Misra

New onset diabetes in COVID 19

10:40-10:50

Discussion

Diabetes and COVID19 II

Basavanagowdappa H

10:50-11:10

Sudhir Bhandari

Diabetes and COVID outcomes

11:10-11:30

A K Singh

Repurposing Metformin for COVID19

11:30-11:40

Discussion

Pot-pourri

Sangram S Biradar, Suman R

11:40-12:00

Rajeev Chawla

AGIs and its relevance in clinical practice

12:00-12:20

Vijay Panikar

Re-examining the role of TZDs in Clinical Care

12:20-12:30

Discussion

Monitoring in Clinical Care

Manoj Chawla

12:30-12:50

Pramila Kalra

Using SMBG data intelligently in App based smart phone digital platform

12:50-13:10

Ranjit Unnikrishnan

Importance of Time In Range in glycemic control

13:10-13:20

Discussion

13:20-13:45

Lunch Break

OADS in Clinical Care

Anuj Maheshwari, Narsingh Verma

13:45-14:05
-->

A K Das

Fixed Drug Combinations - The Indian Experiences

14:05-14:25

A G Unnikrishnan

Durable OADS in T2DM

14:25-14:35

Discussion

Pipeline

Sanjay Agarwal, Anil Kumar

14:35-14:55

Erica Nishimura

Taking the next leap in basal insulin

14:55-15:15

Enrique Morales

R&D perspective of protein in a pill: Paving the way with semaglutide

15:15-15:25

Discussion

Insulin Symposia

Sydney D Souza

15:30-15:50

A G Unnikrishnan

TOTAL control - Convenience and Indian Reality

15:50-16:10

Vijay Vishwanathan

TOTAL control - Wider applicability to Special Populations

16:10-16:20

Discussion

DPP4i in Clinical Care

K M Prasanna Kumar

16:25-16:45

S S Iyengar

Lessons learnt from CAROLINA trial

16:45-17:05

Ganapathy Bantwal

VERIFY trial : Lessons and messages on combination therapy

17:05-17:15

Discussion

Type 1 Beta Cell Symposia

K M Prasanna Kumar

17:20-17:45

Desmond A. Schatz

T1DM - different disease

17:45-18:10

Alvin C. Powers

Pancreas and its differences in Diabetes

18:10-18:30

Discussion

ADA-PRIMER HONOUR LECTURE

K M Prasanna Kumar, S R Aravind, Krishna G. Seshadri

18:30-19:10

Eugene Braunwald

SGLT 2 inhibitors and the birth of Paradigm shift

19:10-19:25

Q & A

K N Manohar, Aravinda Jagadeesha

19:25-19:50

Samuel Dagogo-Jack

Reversal of Prediabetes

19:50-20:10

A Ramachandran

Reversal of Prediabetes and Diabetes: Indian Perspective

20:10-20:25

Discussion

20:25

Close of the conference